Vivotif

Vivotif is an oral typhoid vaccine containing the live, attenuated Salmonella Typhi strain Ty21a. It helps protect against typhoid fever caused by Salmonella Typhi bacteria. This vaccine is designed for oral use and is suitable for travelers to high-risk areas. Store in a cool, dry place away from direct sunlight.

Vivotif is used to help prevent typhoid fever, a serious infection caused by the Salmonella Typhi bacteria. It is commonly recommended for individuals traveling to regions where typhoid fever is prevalent. The vaccine works by stimulating the body's immune system to produce antibodies against the bacteria. It is not a treatment for active typhoid infections.

After taking Vivotif, some individuals may experience mild effects such as stomach discomfort, nausea, or a slight fever. These effects are generally temporary and resolve on their own. The vaccine does not cause typhoid fever, as the bacteria in the vaccine are weakened and cannot cause the disease.

Vivotif should not be taken by individuals with weakened immune systems or those with a history of severe allergic reactions to previous doses of the vaccine. It is important to inform your healthcare provider about any current medications or health conditions before receiving the vaccine. Keep the vaccine in its original packaging until ready for use.

Vivotif may interact with certain medications, including antibiotics and immunosuppressants. Avoid taking antibiotics for at least 72 hours before and after receiving the vaccine, as they may reduce its effectiveness. Consult your healthcare provider if you are unsure about potential interactions with other medications you are taking.